# Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib

> **NCT00582660** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 40 (actual)

## Conditions studied

- Colorectal Adenoma
- Colorectal Carcinoma

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00582660
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00582660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00582660, "Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00582660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*